Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials.
about
Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shockLevosimendan: current data, clinical use and future developmentSurgical implant techniques of left ventricular assist devices: an overview of acute and durable devicesExtracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysisPhysiological Implications of Myocardial Scar StructureThe ICM research agenda on extracorporeal life support.Trends in the use of percutaneous ventricular assist devices: analysis of national inpatient sample data, 2007 through 2012.Clinical outcomes of patients with acute myocardial infarction complicated by severe refractory cardiogenic shock assisted with percutaneous cardiopulmonary support.Mechanical circulatory support in cardiogenic shock - what every interventional cardiologist should know.Revascularization for unprotected left main coronary artery disease: an evolution in clinical decision making.Clinical review: mechanical circulatory support for cardiogenic shock complicating acute myocardial infarction.Intraaortic balloon counterpulsation and microcirculation in cardiogenic shock complicating myocardial infarction: an IABP-SHOCK II substudy.Percutaneous Mechanical Ventricular Support in Acute Cardiac Care: A UK Quaternary Centre Experience Using 2.5L, 3.8L and 5.0L Impella CathetersA novel method for percutaneous insertion of a right ventricular assist device.Benefits of Intraaortic Balloon Support for Myocardial Infarction Patients in Severe Cardiogenic Shock Undergoing Coronary RevascularizationManagement and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock.Efficacy and timing of intra-aortic counterpulsation in patients with ST-elevation myocardial infarction complicated by cardiogenic shock.Outcomes in patients undergoing percutaneous ventricular assist device implantation for cardiogenic shockPercutaneous assist devices in acute myocardial infarction with cardiogenic shock: Review, meta-analysisPercutaneous left ventricular assist device in high risk percutaneous coronary intervention.Total Mechanical Unloading Minimizes Metabolic Demand of Left Ventricle and Dramatically Reduces Infarct Size in Myocardial InfarctionRecent Advances in the Treatment of ST-Segment Elevation Myocardial Infarction.Shear stress, energy losses, and costs: a resolved dilemma of pulsatile cardiac assist devices.Shock in acute myocardial infarction: the Cape Horn for trials?Cardiovascular outcomes using intra-aortic balloon pump in high-risk acute myocardial infarction with or without cardiogenic shock: a meta-analysis.ECMO as a bridge to high-risk rotablation of heavily calcified coronary arteries.Cardiogenic shock in ACS. Part 2: Role of mechanical circulatory support.A ventricular assist device as a bridge to recovery, decision making, or transplantation in patients with advanced cardiac failure.The future of heart transplantation.Defining the role for percutaneous mechanical circulatory support devices for medically refractory heart failure.Supporting the failing myocardium: is intra-aortic balloon pump enough? The IABP-SHOCK II trial.Treatment of acute heart failure in the emergency department.Left ventricular assist devices in patients with end-stage heart failure: suggestion of an alternative treatment based on clinically well-known concepts.Health economics of percutaneous hemodynamic support in the treatment of high-risk cardiac patients: a systematic appraisal of the literature.ST elevation myocardial infarction: recent advances and updates.Important role of mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock.Transplantation in end-stage pulmonary hypertension (Third International Right Heart Failure Summit, part 3).Management of cardiogenic shock.Percutaneous Hemodynamic Support in PCI.The evolution of temporary percutaneous mechanical circulatory support devices: a review of the options and evidence in cardiogenic shock.
P2860
Q24235462-775C050C-6166-4C53-B535-10808C391BF2Q24629274-65D81CD5-433B-477B-9C39-5EA1BE290DB8Q26770313-15D1624A-E47C-4DAE-BB4C-09377BB8E098Q28071264-F33B2D18-30C6-430E-B00D-DA9A48871E1BQ28085424-7DA2B68D-2232-48E5-8852-44B8507E7E0EQ30234573-70FA0A86-4A3E-4321-996B-29CC34F68E39Q30919406-2263E759-78FA-4E3F-863D-53FDFFCB049FQ33822559-C00002D9-6CD9-4BDA-943A-C796DDAEC6E4Q34613403-2305CDBE-BBC5-45F7-B5CF-711F0441A6ADQ35186627-24815FCD-5BC0-4678-A244-6355ADE2AC37Q35559149-66744046-0D11-43BF-8B3E-2D8A74CDF6ABQ35568347-CD52A29E-D0CF-4564-9C13-52B2D83989C3Q35756621-0D0E364F-8A6A-4FEA-ADAE-1AB99DE84DDDQ36019435-51FB3C43-74D6-4CFD-A521-01E64305C3A4Q36092564-E67FCE85-533A-4568-B0B3-5627BA3CBAAEQ36144228-8D20C5DA-E7EC-4033-91A6-D4C6F60E82DBQ36227295-7372ADAC-D3EF-4CE4-803D-31633EE242D2Q36233577-BCE645BB-9D6B-4601-8B75-45FAEF7F8434Q36505924-F2AF837D-86F9-40FB-B40D-2569B31D4912Q36724085-982EC63D-9AF7-45AE-8727-BE69895637EDQ36848829-19CDED1D-2477-4699-B49E-B84A33878682Q37288480-106F9880-FB26-4F9F-A1F1-4FB996B8CC53Q37553593-1B666E96-8557-4C9D-9E8A-2CE38742B81AQ37770822-C93BC4B4-0E2D-436A-A683-B58FF21735B5Q37845021-145AE41D-BDCF-4B9F-A57B-57D1FA4C3522Q37898031-362B7E48-5E0D-4B85-A037-52A497E15D82Q37974559-800DCB51-5293-493A-8C13-36E9C2F24163Q38027734-41F5BFC4-7000-4553-ADF8-AD8688FBA4D0Q38035388-842550D3-AC72-467C-9EB5-50F5956C95CFQ38079766-8173F7E5-EB3C-40EC-9784-A720E0A68216Q38081150-EB8C32E0-6920-4974-8CD4-00E2E568BEE2Q38145265-F0ABA035-9EBB-48CF-B02B-66515647ECD5Q38183815-A98D46CA-96F6-4538-A8C8-C1A393FE1809Q38204771-5D41D5B3-E99E-4422-839B-79E998DFEE59Q38263602-9D9203EA-818B-4DD1-9082-4096EB92F17DQ38284058-293B618D-4394-4128-9B37-FC0BC1900FF5Q38327928-C2D5B1FA-F3E3-455D-AD5F-722B52499B23Q38366956-51CEE2D8-68D4-4D2F-98CC-F682D2FFFDA3Q38418516-BBF5AB18-5D59-4591-BDAB-F90F8493AD36Q38433822-148409CF-66CE-4456-B34A-83F6542E30C2
P2860
Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Percutaneous left ventricular ...... analysis of controlled trials.
@ast
Percutaneous left ventricular ...... analysis of controlled trials.
@en
Percutaneous left ventricular ...... analysis of controlled trials.
@nl
type
label
Percutaneous left ventricular ...... analysis of controlled trials.
@ast
Percutaneous left ventricular ...... analysis of controlled trials.
@en
Percutaneous left ventricular ...... analysis of controlled trials.
@nl
prefLabel
Percutaneous left ventricular ...... analysis of controlled trials.
@ast
Percutaneous left ventricular ...... analysis of controlled trials.
@en
Percutaneous left ventricular ...... analysis of controlled trials.
@nl
P2093
P921
P356
P1476
Percutaneous left ventricular ...... analysis of controlled trials.
@en
P2093
Corstiaan A den Uil
Jin M Cheng
Lucia S D Jewbali
Martin van der Ent
Ron T van Domburg
Sanne E Hoeks
P304
P356
10.1093/EURHEARTJ/EHP292
P577
2009-07-18T00:00:00Z